Acceptability of four intervention components supporting medication adherence in women with breast cancer: a process evaluation of a fractional factorial pilot optimization trial

Sophie M. C. Green*, Nikki Rousseau, Louise H. Hall, David P. French, Christopher D. Graham, Kelly E. Lloyd, Michelle Collinson, Samuel G. Smith, Pei Loo Ow, Christopher Taylor, Daniel Howdon, Robbie Foy, Rebecca Walwyn, Jane Clark, Catherine Parbutt, Jo Waller, Jacqueline Buxton, Sally J. L. Moore, Galina Velikova, Amanda FarrinSamuel G. Smith

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Downloads (Pure)

Abstract

Adjuvant endocrine therapy (AET) reduces mortality in early-stage breast cancer, but adherence is low. We developed a multicomponent intervention to support AET adherence comprising: text messages, information leaflet, acceptance and commitment therapy (ACT), and side-effect website. Guided by the multiphase optimization strategy, the intervention components were tested in the ROSETA pilot optimization trial. Our mixed-methods process evaluation investigated component acceptability. The pilot optimization trial used a 2 4–1 fractional factorial design. Fifty-two women prescribed AET were randomized to one of eight experimental conditions, containing unique component combinations. An acceptability questionnaire was administered 4 months post-randomization, and semi-structured interviews with 20 participants further explored acceptability. Assessments were guided by four constructs of the theoretical framework of acceptability: affective attitude, burden, perceived effectiveness, and coherence. Quantitative and qualitative findings were triangulated to identify agreements/disagreements. There were high overall acceptability scores (median = 14–15/20, range = 11–20). There was agreement between the qualitative and quantitative findings when triangulated. Most participants “liked” or “strongly liked” all components and reported they required low effort to engage in. Between 50% (leaflet) and 65% (SMS) “agreed” or “strongly agreed,” it was clear how each component would help adherence. Perceived effectiveness was mixed, with 35.0% (text messages) to 55.6% (ACT) of participants “agreeing” or “strongly agreeing” that each component would improve their adherence. Interview data provided suggestions for improvements. The four components were acceptable to women with breast cancer and will be refined. Mixed-methods and triangulation were useful methodological approaches and could be applied in other optimization trial process evaluations.

Original languageEnglish
Pages (from-to)1065-1078
Number of pages14
JournalPrevention Science
Volume25
Issue number7
Early online date26 Jul 2024
DOIs
Publication statusPublished - 1 Oct 2024

Funding

This project is funded by the National Institute for Health Research (NIHR) under its NIHR Fellowships Program (Grant Reference Number NIHR300588; to Samuel Smith). Smith is also supported by a Yorkshire Cancer Research Fellowship (L417). Foy is supported by grant funding from the National Institute for Health and Care Research and Yorkshire Cancer Research. DF is supported by the NIHR Manchester Biomedical Research Centre (IS-BRC-1215-20007 and NIHR203308). MC is supported by grant funding from NIHR, Yorkshire Cancer Research and Breast Cancer Now. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • process evaluation
  • acceptability
  • factorial
  • breast cancer
  • medication adherence

Fingerprint

Dive into the research topics of 'Acceptability of four intervention components supporting medication adherence in women with breast cancer: a process evaluation of a fractional factorial pilot optimization trial'. Together they form a unique fingerprint.

Cite this